nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RARA—amyotrophic lateral sclerosis	0.75	1	CbGaD
Isotretinoin—RARG—tongue—amyotrophic lateral sclerosis	0.0037	0.157	CbGeAlD
Isotretinoin—Cardiac murmur—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0235	CcSEcCtD
Isotretinoin—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.00314	0.0229	CcSEcCtD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00302	0.0363	CbGpPWpGaD
Isotretinoin—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.00279	0.0204	CcSEcCtD
Isotretinoin—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00279	0.0204	CcSEcCtD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00276	0.0332	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.0027	0.0326	CbGpPWpGaD
Isotretinoin—RARG—Retinoic acid receptors-mediated signaling—RARA—amyotrophic lateral sclerosis	0.00269	0.0324	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00259	0.0313	CbGpPWpGaD
Isotretinoin—RXRG—Retinoic acid receptors-mediated signaling—RARA—amyotrophic lateral sclerosis	0.00246	0.0296	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00243	0.0293	CbGpPWpGaD
Isotretinoin—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0177	CcSEcCtD
Isotretinoin—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0177	CcSEcCtD
Isotretinoin—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0177	CcSEcCtD
Isotretinoin—RARB—Retinoic acid receptors-mediated signaling—RARA—amyotrophic lateral sclerosis	0.00241	0.0291	CbGpPWpGaD
Isotretinoin—Acitretin—RARA—amyotrophic lateral sclerosis	0.00238	0.38	CrCbGaD
Isotretinoin—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0171	CcSEcCtD
Isotretinoin—RXRB—Retinoic acid receptors-mediated signaling—RARA—amyotrophic lateral sclerosis	0.00231	0.0279	CbGpPWpGaD
Isotretinoin—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0168	CcSEcCtD
Isotretinoin—Alitretinoin—RARA—amyotrophic lateral sclerosis	0.00228	0.364	CrCbGaD
Isotretinoin—RARG—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00223	0.0268	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00218	0.0263	CbGpPWpGaD
Isotretinoin—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0021	0.0153	CcSEcCtD
Isotretinoin—RXRG—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00204	0.0245	CbGpPWpGaD
Isotretinoin—RARG—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00202	0.0243	CbGpPWpGaD
Isotretinoin—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.002	0.0146	CcSEcCtD
Isotretinoin—RARB—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.002	0.0241	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00191	0.0231	CbGpPWpGaD
Isotretinoin—RXRG—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00184	0.0222	CbGpPWpGaD
Isotretinoin—RARB—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00181	0.0218	CbGpPWpGaD
Isotretinoin—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0132	CcSEcCtD
Isotretinoin—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.013	CcSEcCtD
Isotretinoin—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00178	0.013	CcSEcCtD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00176	0.0212	CbGpPWpGaD
Isotretinoin—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0128	CcSEcCtD
Isotretinoin—RXRB—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00173	0.0209	CbGpPWpGaD
Isotretinoin—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0124	CcSEcCtD
Isotretinoin—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0118	CcSEcCtD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00161	0.0194	CbGpPWpGaD
Isotretinoin—Tretinoin—RARA—amyotrophic lateral sclerosis	0.0016	0.256	CrCbGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00158	0.019	CbGpPWpGaD
Isotretinoin—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0115	CcSEcCtD
Isotretinoin—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0115	CcSEcCtD
Isotretinoin—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0113	CcSEcCtD
Isotretinoin—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0111	CcSEcCtD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00151	0.0182	CbGpPWpGaD
Isotretinoin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0107	CcSEcCtD
Isotretinoin—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0106	CcSEcCtD
Isotretinoin—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0105	CcSEcCtD
Isotretinoin—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0103	CcSEcCtD
Isotretinoin—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0103	CcSEcCtD
Isotretinoin—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0103	CcSEcCtD
Isotretinoin—RXRG—medulla oblongata—amyotrophic lateral sclerosis	0.00136	0.0576	CbGeAlD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00135	0.0163	CbGpPWpGaD
Isotretinoin—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00951	CcSEcCtD
Isotretinoin—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00935	CcSEcCtD
Isotretinoin—RXRG—spinal cord—amyotrophic lateral sclerosis	0.00121	0.0514	CbGeAlD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—RARA—amyotrophic lateral sclerosis	0.00121	0.0145	CbGpPWpGaD
Isotretinoin—RXRA—nervous system—amyotrophic lateral sclerosis	0.00116	0.0493	CbGeAlD
Isotretinoin—RXRA—central nervous system—amyotrophic lateral sclerosis	0.00112	0.0475	CbGeAlD
Isotretinoin—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00812	CcSEcCtD
Isotretinoin—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00801	CcSEcCtD
Isotretinoin—Gout—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0078	CcSEcCtD
Isotretinoin—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00775	CcSEcCtD
Isotretinoin—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0077	CcSEcCtD
Isotretinoin—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0077	CcSEcCtD
Isotretinoin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0077	CcSEcCtD
Isotretinoin—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0077	CcSEcCtD
Isotretinoin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00765	CcSEcCtD
Isotretinoin—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00746	CcSEcCtD
Isotretinoin—RXRG—nervous system—amyotrophic lateral sclerosis	0.00102	0.0433	CbGeAlD
Isotretinoin—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00741	CcSEcCtD
Isotretinoin—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00737	CcSEcCtD
Isotretinoin—RXRA—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.000998	0.012	CbGpPWpGaD
Isotretinoin—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.000998	0.00728	CcSEcCtD
Isotretinoin—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.000998	0.00728	CcSEcCtD
Isotretinoin—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00724	CcSEcCtD
Isotretinoin—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.000986	0.0072	CcSEcCtD
Isotretinoin—RARB—cerebellum—amyotrophic lateral sclerosis	0.000983	0.0417	CbGeAlD
Isotretinoin—RXRG—central nervous system—amyotrophic lateral sclerosis	0.000983	0.0417	CbGeAlD
Isotretinoin—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000963	0.00703	CcSEcCtD
Isotretinoin—RXRB—nervous system—amyotrophic lateral sclerosis	0.00096	0.0407	CbGeAlD
Isotretinoin—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00695	CcSEcCtD
Isotretinoin—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.000937	0.00684	CcSEcCtD
Isotretinoin—RXRB—central nervous system—amyotrophic lateral sclerosis	0.000924	0.0392	CbGeAlD
Isotretinoin—Coma—Riluzole—amyotrophic lateral sclerosis	0.000912	0.00665	CcSEcCtD
Isotretinoin—RXRA—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.000904	0.0109	CbGpPWpGaD
Isotretinoin—RXRB—cerebellum—amyotrophic lateral sclerosis	0.000903	0.0383	CbGeAlD
Isotretinoin—RXRA—brain—amyotrophic lateral sclerosis	0.000889	0.0377	CbGeAlD
Isotretinoin—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.000888	0.00648	CcSEcCtD
Isotretinoin—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.000866	0.00632	CcSEcCtD
Isotretinoin—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.000857	0.00626	CcSEcCtD
Isotretinoin—RARG—nervous system—amyotrophic lateral sclerosis	0.000852	0.0361	CbGeAlD
Isotretinoin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000849	0.00619	CcSEcCtD
Isotretinoin—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.000849	0.00619	CcSEcCtD
Isotretinoin—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00613	CcSEcCtD
Isotretinoin—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.000833	0.00608	CcSEcCtD
Isotretinoin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000833	0.00608	CcSEcCtD
Isotretinoin—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.000825	0.00602	CcSEcCtD
Isotretinoin—RARG—central nervous system—amyotrophic lateral sclerosis	0.00082	0.0348	CbGeAlD
Isotretinoin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.000809	0.00591	CcSEcCtD
Isotretinoin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000806	0.00588	CcSEcCtD
Isotretinoin—RARG—cerebellum—amyotrophic lateral sclerosis	0.000802	0.034	CbGeAlD
Isotretinoin—RARA—nervous system—amyotrophic lateral sclerosis	0.000801	0.034	CbGeAlD
Isotretinoin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000798	0.00583	CcSEcCtD
Isotretinoin—RARB—brain—amyotrophic lateral sclerosis	0.000798	0.0338	CbGeAlD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.000788	0.0095	CbGpPWpGaD
Isotretinoin—RXRG—brain—amyotrophic lateral sclerosis	0.00078	0.0331	CbGeAlD
Isotretinoin—RARA—central nervous system—amyotrophic lateral sclerosis	0.000771	0.0327	CbGeAlD
Isotretinoin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.000767	0.0056	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000763	0.0092	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000761	0.00917	CbGpPWpGaD
Isotretinoin—RARA—cerebellum—amyotrophic lateral sclerosis	0.000754	0.032	CbGeAlD
Isotretinoin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000745	0.00544	CcSEcCtD
Isotretinoin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000742	0.00542	CcSEcCtD
Isotretinoin—RXRB—brain—amyotrophic lateral sclerosis	0.000734	0.0311	CbGeAlD
Isotretinoin—RXRA—Organelle biogenesis and maintenance—GFM1—amyotrophic lateral sclerosis	0.00073	0.0088	CbGpPWpGaD
Isotretinoin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000724	0.00529	CcSEcCtD
Isotretinoin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000724	0.00529	CcSEcCtD
Isotretinoin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000713	0.0052	CcSEcCtD
Isotretinoin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000707	0.00516	CcSEcCtD
Isotretinoin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000699	0.0051	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000698	0.00841	CbGpPWpGaD
Isotretinoin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000689	0.00503	CcSEcCtD
Isotretinoin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000686	0.00501	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000685	0.00825	CbGpPWpGaD
Isotretinoin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000673	0.00492	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000673	0.00811	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000656	0.00791	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000656	0.00791	CbGpPWpGaD
Isotretinoin—RARG—brain—amyotrophic lateral sclerosis	0.000651	0.0276	CbGeAlD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000645	0.00778	CbGpPWpGaD
Isotretinoin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000641	0.00468	CcSEcCtD
Isotretinoin—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00063	0.0046	CcSEcCtD
Isotretinoin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000626	0.00457	CcSEcCtD
Isotretinoin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000626	0.00457	CcSEcCtD
Isotretinoin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000614	0.00448	CcSEcCtD
Isotretinoin—RARA—brain—amyotrophic lateral sclerosis	0.000612	0.026	CbGeAlD
Isotretinoin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0006	0.00438	CcSEcCtD
Isotretinoin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000585	0.00427	CcSEcCtD
Isotretinoin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000585	0.00427	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000578	0.00697	CbGpPWpGaD
Isotretinoin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000578	0.00422	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000571	0.00417	CcSEcCtD
Isotretinoin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00057	0.00416	CcSEcCtD
Isotretinoin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000566	0.00413	CcSEcCtD
Isotretinoin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000561	0.0041	CcSEcCtD
Isotretinoin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000558	0.00407	CcSEcCtD
Isotretinoin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000558	0.00407	CcSEcCtD
Isotretinoin—Depression—Riluzole—amyotrophic lateral sclerosis	0.000556	0.00406	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00055	0.00402	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000549	0.00661	CbGpPWpGaD
Isotretinoin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000547	0.00399	CcSEcCtD
Isotretinoin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000547	0.00399	CcSEcCtD
Isotretinoin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000544	0.00397	CcSEcCtD
Isotretinoin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000542	0.00396	CcSEcCtD
Isotretinoin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000535	0.0039	CcSEcCtD
Isotretinoin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000532	0.00388	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000529	0.00638	CbGpPWpGaD
Isotretinoin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000526	0.00384	CcSEcCtD
Isotretinoin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000524	0.00382	CcSEcCtD
Isotretinoin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000521	0.0038	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000519	0.00625	CbGpPWpGaD
Isotretinoin—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000503	0.00367	CcSEcCtD
Isotretinoin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000501	0.00366	CcSEcCtD
Isotretinoin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000501	0.00366	CcSEcCtD
Isotretinoin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000498	0.00364	CcSEcCtD
Isotretinoin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000498	0.00364	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000497	0.006	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000497	0.006	CbGpPWpGaD
Isotretinoin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000497	0.00363	CcSEcCtD
Isotretinoin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000495	0.00361	CcSEcCtD
Isotretinoin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000493	0.0036	CcSEcCtD
Isotretinoin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00358	CcSEcCtD
Isotretinoin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000474	0.00346	CcSEcCtD
Isotretinoin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000468	0.00342	CcSEcCtD
Isotretinoin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000455	0.00332	CcSEcCtD
Isotretinoin—Chills—Riluzole—amyotrophic lateral sclerosis	0.000449	0.00328	CcSEcCtD
Isotretinoin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00327	CcSEcCtD
Isotretinoin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000443	0.00323	CcSEcCtD
Isotretinoin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000439	0.0032	CcSEcCtD
Isotretinoin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000436	0.00318	CcSEcCtD
Isotretinoin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00314	CcSEcCtD
Isotretinoin—Tension—Riluzole—amyotrophic lateral sclerosis	0.000428	0.00312	CcSEcCtD
Isotretinoin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000424	0.00309	CcSEcCtD
Isotretinoin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00308	CcSEcCtD
Isotretinoin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000409	0.00298	CcSEcCtD
Isotretinoin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000405	0.00295	CcSEcCtD
Isotretinoin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000403	0.00294	CcSEcCtD
Isotretinoin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000401	0.00293	CcSEcCtD
Isotretinoin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000393	0.00287	CcSEcCtD
Isotretinoin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00285	CcSEcCtD
Isotretinoin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000385	0.00281	CcSEcCtD
Isotretinoin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000383	0.0028	CcSEcCtD
Isotretinoin—Cough—Riluzole—amyotrophic lateral sclerosis	0.000381	0.00278	CcSEcCtD
Isotretinoin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000378	0.00276	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000377	0.00455	CbGpPWpGaD
Isotretinoin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000377	0.00275	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000373	0.0045	CbGpPWpGaD
Isotretinoin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000371	0.00271	CcSEcCtD
Isotretinoin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000371	0.00271	CcSEcCtD
Isotretinoin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000371	0.00271	CcSEcCtD
Isotretinoin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00037	0.0027	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000369	0.00269	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000367	0.00443	CbGpPWpGaD
Isotretinoin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000367	0.00268	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000366	0.00441	CbGpPWpGaD
Isotretinoin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000363	0.00265	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000362	0.00436	CbGpPWpGaD
Isotretinoin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000359	0.00262	CcSEcCtD
Isotretinoin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000356	0.0026	CcSEcCtD
Isotretinoin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000356	0.0026	CcSEcCtD
Isotretinoin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000354	0.00258	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000351	0.00423	CbGpPWpGaD
Isotretinoin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00035	0.00256	CcSEcCtD
Isotretinoin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000349	0.00255	CcSEcCtD
Isotretinoin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000348	0.00254	CcSEcCtD
Isotretinoin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000347	0.00254	CcSEcCtD
Isotretinoin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000346	0.00252	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000345	0.00415	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000344	0.00251	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000342	0.00412	CbGpPWpGaD
Isotretinoin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00248	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000336	0.00405	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000336	0.00405	CbGpPWpGaD
Isotretinoin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000333	0.00243	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00033	0.00398	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00033	0.00397	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000327	0.00394	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000324	0.00237	CcSEcCtD
Isotretinoin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000322	0.00235	CcSEcCtD
Isotretinoin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00032	0.00233	CcSEcCtD
Isotretinoin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000317	0.00232	CcSEcCtD
Isotretinoin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000316	0.00231	CcSEcCtD
Isotretinoin—RARA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000316	0.00381	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000316	0.00381	CbGpPWpGaD
Isotretinoin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000313	0.00229	CcSEcCtD
Isotretinoin—RARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000312	0.00377	CbGpPWpGaD
Isotretinoin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000309	0.00226	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000307	0.00224	CcSEcCtD
Isotretinoin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000307	0.00224	CcSEcCtD
Isotretinoin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000304	0.00222	CcSEcCtD
Isotretinoin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000304	0.00222	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000304	0.00366	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000293	0.00214	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00212	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000286	0.00344	CbGpPWpGaD
Isotretinoin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000283	0.00206	CcSEcCtD
Isotretinoin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000281	0.00205	CcSEcCtD
Isotretinoin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000281	0.00205	CcSEcCtD
Isotretinoin—RARB—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00028	0.00338	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000279	0.00336	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000278	0.00335	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000274	0.0033	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000273	0.00329	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000269	0.00324	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000269	0.00324	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000266	0.00321	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000262	0.00191	CcSEcCtD
Isotretinoin—RXRB—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000261	0.00315	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000259	0.00312	CbGpPWpGaD
Isotretinoin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000255	0.00186	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000255	0.00308	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000255	0.00307	CbGpPWpGaD
Isotretinoin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000252	0.00184	CcSEcCtD
Isotretinoin—RARB—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00025	0.00301	CbGpPWpGaD
Isotretinoin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000244	0.00178	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000239	0.00289	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000239	0.00289	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000239	0.00289	CbGpPWpGaD
Isotretinoin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000235	0.00172	CcSEcCtD
Isotretinoin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000226	0.00165	CcSEcCtD
Isotretinoin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000224	0.00164	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000224	0.0027	CbGpPWpGaD
Isotretinoin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000224	0.00164	CcSEcCtD
Isotretinoin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000223	0.00163	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000218	0.00263	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000215	0.00259	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000214	0.00258	CbGpPWpGaD
Isotretinoin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000211	0.00154	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000205	0.00248	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000202	0.00244	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000199	0.0024	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000193	0.00233	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.00019	0.00229	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000189	0.00227	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000185	0.00223	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000185	0.00222	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000183	0.0022	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000179	0.00216	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000177	0.00213	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000174	0.0021	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000174	0.00209	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000173	0.00209	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000172	0.00207	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000166	0.002	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000166	0.002	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000165	0.00199	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000164	0.00198	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000161	0.00194	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000159	0.00192	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000157	0.00189	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000156	0.00188	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000154	0.00186	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000154	0.00186	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000149	0.0018	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000149	0.0018	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000146	0.00176	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000146	0.00176	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000144	0.00174	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00014	0.00169	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00014	0.00168	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000136	0.00164	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000134	0.00161	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000133	0.0016	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000131	0.00158	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000127	0.00153	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000126	0.00152	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000125	0.0015	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000121	0.00146	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000119	0.00144	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000116	0.0014	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000115	0.00139	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000112	0.00135	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000112	0.00135	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000107	0.0013	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000107	0.00129	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000101	0.00122	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	9.9e-05	0.00119	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—VAPB—amyotrophic lateral sclerosis	9.71e-05	0.00117	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TPK1—amyotrophic lateral sclerosis	9.71e-05	0.00117	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	9.51e-05	0.00115	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	9.12e-05	0.0011	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.05e-05	0.00109	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—VAPA—amyotrophic lateral sclerosis	8.88e-05	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	8.65e-05	0.00104	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.6e-05	0.00104	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.6e-05	0.00104	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.25e-05	0.000995	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—FUS—amyotrophic lateral sclerosis	8.04e-05	0.000969	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	7.79e-05	0.000939	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—FIG4—amyotrophic lateral sclerosis	7.76e-05	0.000935	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.67e-05	0.000924	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	7.28e-05	0.000877	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.19e-05	0.000866	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—DAO—amyotrophic lateral sclerosis	7.02e-05	0.000846	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.89e-05	0.000831	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RARA—amyotrophic lateral sclerosis	6.56e-05	0.00079	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	6.03e-05	0.000727	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	5.6e-05	0.000675	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PLB1—amyotrophic lateral sclerosis	5.32e-05	0.000641	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSR—amyotrophic lateral sclerosis	4.91e-05	0.000592	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	4.75e-05	0.000573	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.47e-05	0.000539	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CHAT—amyotrophic lateral sclerosis	4.03e-05	0.000486	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.68e-05	0.000443	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.59e-05	0.000433	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.52e-05	0.000304	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.47e-05	0.000298	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.22e-05	0.000268	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.17e-05	0.000261	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.99e-05	0.00024	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—APOE—amyotrophic lateral sclerosis	1.64e-05	0.000197	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.12e-05	0.000135	CbGpPWpGaD
